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Abstract The reconstruction of large bone defects after
injury or tumor resection often requires the use of bone
substitution. Artificial scaffolds based on synthetic bio-
materials can overcome disadvantages of autologous bone
grafts, like limited availability and donor side morbidity.
Among them, scaffolds based on nanofibers offer great
advantages. They mimic the extracellular matrix, can be
used as a carrier for growth factors and allow the differ-
entiation of human mesenchymal stem cells. Differentia-
tion is triggered by a series of signaling processes,
including integrin and bone morphogenetic protein (BMP),
which act in a cooperative manner. The aim of this study
was to analyze whether these processes can be remodeled
in artificial poly-(l)-lactide acid (PLLA) based nanofiber
scaffolds in vivo. Electrospun matrices composed of
PLLA-collagen type I or BMP-2 incorporated PLLA-col-
lagen type I were implanted in calvarial critical size defects
in rats. Cranial CT-scans were taken 4, 8 and 12 weeks
after implantation. Specimens obtained after euthanasia
were processed for histology and immunostainings on
osteocalcin, BMP-2 and Smad5. After implantation the
scaffolds were inhomogeneously colonized and cells were
only present in wrinkle- or channel-like structures. Ossifi-
cation was detected only in focal areas of the scaffold. This
was independent of whether BMP-2 was incorporated in
the scaffold. However, cells that migrated into the scaffold
showed an increased ratio of osteocalcin and Smad5
positive cells compared to empty defects. Furthermore, in
case of BMP-2 incorporated PLLA-collagen type I scaf-
folds, 4 weeks after implantation approximately 40 % of
the cells stained positive for BMP-2 indicating an autocrine
process of the ingrown cells. These findings indicate that a
cooperative effect between BMP-2 and collagen type I can
be transferred to PLLA nanofibers and furthermore, that
this effect is active in vivo. However, this had no effect on
bone formation. The reason for this seems to be an
unbalanced colonization of the scaffolds with cells, due to
insufficient pore size.
1 Introduction
Surgical reconstruction of bone defects frequently requires
the use of graft material. Beside autologous bone grafts,
artificial bone grafts based on synthetic biomaterials such
as metals, polymers, porous ceramics, hydroxyapatite,
collagen sponges or hydrogels, as well as several com-
posites, have been developed recently [1–3]. Among them
scaffolds based on nanofibers offer several advantages
[4–6]. They are thought to mimic the extracellular matrix
(ECM) [7–10] and allow differentiation of human mesen-
chymal stem cells (hMSC) towards osteoblasts. However,
this process depends on the chemical composition of the
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nanofibers. In comparison to other a-(hydroxyester)-based
nanofibrous scaffolds, poly-(l)-lactide acid (PLLA) scaf-
folds support the highest rate of proliferation of mesen-
chymal stem cells [11] with a tendency to higher cell
densities [12, 13]. An initial down regulation of genes
associated with the osteoblast linage [12, 14] can be
eliminated by functionalisation of the nanofibers either by
blending with collagen type I [15] or incorporation of
recombinant bone morphogenic protein 2 (BMP-2) in vitro
[12]. With respect to bone formation, PLLA nanofiber
scaffolds are superior compared to solid wall scaffolds in
vivo, due to the nanofibrous geometry [16]. Addition of
BMP-2 enhances bone formation, independent of whether
BMP is incorporated directly [17], in core–shell nanotubes
[18] or loaded in PLGA/HAp nanofibers [19].
Bone regeneration is controlled by a variety of growth
factors [20, 21], as well as interactions with the ECM. It is
known that the adhesion to collagen I via a2b1 integrin is
sufficient to induce osteogenic differentiation of hMSC0s,
even in the absence of exogenous stimuli [22, 23]. Fur-
thermore evidence can be found that this integrin signaling
pathway is influenced by the BMP-2/Smad signaling.
BMP-2 induces formation of integrins on osteoblasts [24,
25]. This, in interaction with the ECM, influence the BMP-
function [25] resulting in migration, activation of focal
adherence kinase and formation of focal adhesion [26, 27].
Suzawa et al. [28] found evidence, that the downstream
pathway of integrin is involved in Smad1 signals, activated
by BMP-2 and provides a possible mechanism for coop-
eration between intracellular signals activated by integrin
and BMP receptors in osteoblastic cells. We recently
transferred this cooperative effect between collagen and
BMP signaling pathway into PLLA based nanofiber scaf-
folds. In vitro, these scaffolds exhibit a strong osteoin-
ductive potential, accompanied by an up regulation of focal
adherence kinase and Smad5, key proteins in BMP-2 and
integrin signaling [29].
In order to analyze whether this cooperative effect can
be induced by BMP-2 enwoven PLLA-collagen type-I
nanofibers in vivo, scaffolds were implanted into critical
size defects in rats and analyzed with respect to bone for-
mation in a time dependent manner.
2 Materials and methods
2.1 Construction of nanofibers and characterization
The preparation of PLLA-collagen type I blend nanofibers,
as well as the incorporation of BMP-2 into PLLA nanofibers
by electrospinning, has been reported earlier [29]. Briefly,
PLLA and collagen were dissolved in hexafluoroisopropanol
(HFIP) in a 4:1 ratio resulting in a 4.5 % (w/v) polymer
solution. The spinning solution had a surface tension of
18.33 ± 0.03 mN/m, a viscosity of 1.529 PaS and a con-
ductivity of*4.7 ls/cm. Spinning process was performed at
a flow rate of 14 ll/min with an applied voltage of 10–18 kV
and an electrode distance of 15 cm. To incorporate BMP-2
into the nanofibers, 25 lg lyophilized BMP-2 (Reliatech,
Braunschweig Germany) was dissolved in 125 ll 50 mM
acetic acid and stabilized by addition of 25 ll fetal calf
serum (FCS). This mixture was emulsified in 2.5 ml of a
4.5 % PLLA-collagen type I solution (4:1) over a period of
1 min using a vortex mixer (MS 2 Minishaker IKA;
2500 rpm). The spinning process was performed at a flow
rate of 14 ll/min with an applied voltage of 10–18 kV and a
distance of 15 cm.
2.2 Animals
Sixty, five-month-old Sprague–Dawley rats (Harlan Win-
kelmann, Borchen, Germany) were used in the experiment.
The animals were kept in individual plastic cages (Macr-
olon Type III) in a room held at a constant temperature of
22.1 C, with a 12 h light/dark cycle. They had free access
to water and standard laboratory pellets (LASQCdiet
Rod16 Rad, LASVendi, Soest, Germany). All experiments
were carried out in accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of
the NIH and approved by the local Animal Ethics Com-
mittee (V 54–19 c 20–15 (1) MR 20/21- Nr. 34/2009).
Following the 3-R principle (replace, reduce and refine)
for animal testing a former control group (empty defect)
was not re-operated. All animals were operated by the
same surgeon within 12 month and healing outcomes were
followed over a period of 12 weeks.
2.3 Surgery
Animals were divided in two groups and surgeries were
preformed as described earlier [17]. Defects were filled
with either PLLA-collagen type-I or BMP-2 enwoven
PLLA-collagen type-I nanofiber scaffolds.
2.4 Dual-source CCT
Radiographic evaluation was done under general anesthe-
sia 4, 8 and 12 weeks after surgery using cranial computer
tomography (CCT) imaging (Somatom Definition, Siemens
Medical Systems, Erlangen, Germany) with a resolution of
0.3 mm. Radiological density was measured by placing a
region of interest (ROI) of the same size as the defect over
each data set (Leonardo, Siemens Medical Systems,
Erlangen, Germany).
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2.5 Harvesting of tissue and sectioning of test
specimens
Animals of each group were sacrificed by CO2-asphyxia-
tion after 4, 8 and 12 weeks. Blood samples were taken
from animals sacrificed after 4 weeks and inflammatory
parameters like C-reactive protein (CRP) and haptoglobin
were analyzed. The defect sites were removed from dead
animals together with a small amount of surrounding bone,
skin and soft connective tissue. These samples were
immediately fixed in 4 % buffered formalin for 3 days and
then decalcified in an EDTA-solution (Osteosoft, Merck,
Darmstadt, Germany) over a period of 18 days. After
trimming the bone specimens with a precision saw, they
were dehydrated in graded alcohol solution and cedar wood
oil and embedded in paraffin. Sections were cut at 5 lm
with a 40 stainless-steel blade on a rotation microtome
(RM2055, Leica Microsystems, 158 Bensheim, Germany).
2.6 Histological and immunohistological staining
After removal of paraffin using Xylene and re-hydration by
decreasing alcohol series histological staining was per-
formed with Masson Goldner (MG) formulations according
to standard protocols. For immunohistological staining
endogenous peroxidase activity was quenched with a 4 %
hydrogen peroxide solution after re-hydration. Normal
horse serum (Santa Cruz, Heidelberg, Germany) was used
in order to block unspecific bindings. Then slices were
incubated over night with a polyclonal IgG antibody against
either osteocalcin (1:50; FL-100, Santa Cruz, Heidelberg,
Germany), BMP-2 (1:25; N-14, Santa Cruz Heidelberg,
Germany) or Smad5 (1:25; D-20, Santa Cruz
Heidelberg, Germany). Sections were then incubated with a
biotinylated secondary antibody (Santa Cruz, Heidelberg,
Germany) diluted 1:50 for 30 min at room temperature. An
avidin–biotin complex detection system coupled with DAB
as a chromogen (Santa Cruz, Heidelberg, Germany) was used
to visualize antibody binding after 20 min incubation time at
room temperature. Finally, all sections were counterstained
with Gill’s hematoxylin solution (Santa Cruz, Heidelberg,
Germany) diluted 1:2 for 10 s. Negative controls without
primary antibody incubation were carried along together with
each of the previously described staining.
2.7 Histological analysis
Histological analysis was carried out using a digital
microscope (DM5000, Leica Microsystems, Bensheim,
Germany) and QUIPS analysis software (Leica Microsys-
tems, Bensheim, Germany) as described in [17]. Cell
counts were performed in four fields of at least six
specimens, ranging from one defect end to the other, using
primary magnifications of 40/20 fold.
2.8 Statistical analysis
Analysis of variance (ANOVA) was used to evaluate the
differences between experimental groups and control group
as well as between different points of time in each group.
Data are given as means ± standard deviations. The level
of significance was set at P \ 0.05.
3 Results
Four animals had to be sacrificed 1 day after surgery due to
neurological deficits but all remaining animals survived
and the implant sites healed well. Body weight increased
during 3 month from 278 to 435 g in the PLLA-collagen
group and from 279 to 441 g in the PLLA-collagen-BMP
group. Serum blood analysis of CRP as well as haptoglobin
yielded no signs of infection or inflammation. Levels of
9.67 ± 0.98 and 9.84 ± 1.99 mg/L of CRP and 0.97 ±
0.30 and 0.78 ± 0.33 mg/dL of haptoglobin were found in
the PLLA-collagen group and in the PLLA-collagen-BMP-
2 group 4 weeks after surgery, without significant dif-
ferences between the groups. Animals receiving either
PLLA-collagen or PLLA-collagen-BMP-2 nanofiber scaf-
folds showed firm fixation of the implants on palpation.
3.1 Effects on colonization
To analyze the impact of PLLA-collagen type-I and BMP-2
enwoven PLLA-collagen type-I nanofibers on bone healing,
we performed total cell count, analyzed the formation of
hard callus determined by Masson Goldner staining and
determined bone formation using CT scans. As shown in
Fig. 1a only a few cells migrate into the scaffold resulting in
a slight increase as compared to control defect. It is notable
that the distribution of the cells was inhomogenous. Cells
were accumulated within wrinkles or channels throughout
the scaffold leaving the main part un-colonized (Fig. 1e).
Furthermore formation of hard callus failed to appear in
most areas of the defect as determined by Masson Goldner
staining (Fig. 1c, d and Fig. 1b control). These findings were
supported by CT-scans. Within three month, bone density
was lower as compared to empty controls with no significant
differences between the two treatment groups (Fig. 2).
To analyze whether this delay in bone formation is either
due to a missing cell migration or down regulation of oste-
ocalcin, we next determined the amount of osteocalcin
positive cells within the scaffold. As shown in Fig. 3a more
osteocalcin positive cells were detected when either PLLA-
collagen type-I or BMP-2 enwoved PLLA-collagen type-I
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nanofibers were implanted into the defect as compared to
empty defects. However significant differences were
detected after 4 weeks in the BMP-2 enwoven PLLA-col-
lagen group and after 12 weeks in the PLLA-collagen group.
The maintenance of the osteoblast phenotype was ana-
lyzed by determining the amount of Smad5 and BMP-2
positive cells within each scaffold. As shown in Fig. 3b
three times more Smad5 positive cells were found in
PLLA-collagen nanofiber scaffold compared to empty
defects. Here the incorporation of BMP-2 had no further
impact on Smad5 expression. Nevertheless, focusing on
BMP-2 positive cells the PLLA-collagen nanofiber scaf-
folds had only late stage effects. Here incorporation of
BMP-2 results in significant more BMP-2 expressing cells,
especially in early stages of defect healing (Fig. 3c).
4 Discussion
Tissue-engineered scaffolds should be analogous to native
ECM in terms of both chemical composition and physical
structure. Polymeric nanofiber matrix, with its nanoscaled
nonwoven fibrous structure is a suitable material to mimic
ECM [30]. Nevertheless, the polymer itself influences cell
behavior. PLLA nanofibers allow cell growth and differ-
entiation although an initial down regulation of genes
associated with the osteoblast lineage can be observed [12,
14]. It had been shown earlier that this effect can be
overcome by functionalisation of nanofibers either by BMP
incorporation or blending with collagen type I in vitro [12,
15]. PLLA nanofiber scaffolds––implanted into critical size
defects––were colonized homogeneously by cells and
induced bone formation when functionalized with BMP-2
[17]. In contrast, the PLLA-collagen nanofiber scaffolds we
implanted into critical size defects were less colonized and
distribution of cells was inhomogeneous and restricted to
wrinkles or channels. This was accompanied by reduced
bone densities and hard callus formation––independent of
BMP-2 incorporation.
However, the increased ratio of osteocalcin positive
cells––localized within the scaffolds––shows that the
osteoinductive potential observed in vitro [15, 29] is
Fig. 1 Influence of nanofiber implant on cell densities and callus
formation Mean cell densities (a), and Microphotographs of masson
goldner stained samples of negative control (b), PLLA-collagen type I
(c), and PLLA-collagen type I/BMP-2 (d), 12 weeks after implanta-
tion into critical size defects. Detail screen showing cells accumulated
mainly in wrinkles or channels (e)
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maintained in vivo in principal. Furthermore, the use of
PLLA-collagen type I nanofiber scaffolds resulted in an
enhanced staining of Smad5 as compared to controls. In
addition approximately 40 % of the cells stained positive
for BMP-2 when BMP-2 enwoven PLLA-collagen type-I
scaffolds were implanted. This was more as compared to
the corresponding scaffolds without BMP-2, as well as to
PLLA and BMP-2 enwoven PLLA nanofiber scaffolds as
published earlier [17]. These findings indicate that the
cooperative effect between BMP-2 and collagen type-I as
postulated by [28] can be transferred to PLLA nanofibers
and theoretically maintains in vivo.
Despite the osteoinductive potential, the scaffolds did
not induce bone formation in vivo due to poor cell colo-
nization which can be interpreted as a tribute to the pore
size of the scaffolds. As reported earlier PLLA-collagen
type-I nanofiber scaffolds exhibited a pore size of 2 lm
which is reduced after BMP-2 incorporation [29]. To
achieve bone ingrowths into porous scaffolds pore sizes of
approximately 50–125 lm [31] or even higher [32] had
been reported. In case of nanofiber scaffolds pore sizes
seem to play another role. A recently published review [33]
comparing different nanofiber/cell combinations found
optimal pore diameter for nanofiber scaffolds ranging from
5 to 50 lm. With respect to PLLA nanofibers produced
from DCM pore diameter of 30 lm were reported [34]
while PLLA-collagen blend nanofiber scaffolds showed
pore diameter below 2 lm [35]. Here the low pore diam-
eter might be one reason for the lack of colonization.
Another reason might be the presence of solvent resi-
dues. In gelatin blended PCL nanofibers HFIP residues up
to 16,600 ppm were detected, depending on the gelatin
content and treatment of the fibers [36] while DCM resi-
dues in PLGA nanofibers were about 400 ppm [19].
Fig. 2 Influence of nanofiber
implant on defect calcification
Radiological density [HU] of
defect areas measured by cranial
CT-scans (a), and 3D
reconstructions of cranial
CT-scans (b), PLLA-collagen
type I (c), and PLLA-collagen
type I/BMP-2, each 4 weeks
after implantation
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Bearing in mind that in vitro cells proliferate and differ-
entiate on PLLA nanofiber scaffolds using both HFIP or
DCM as solvent, solvent residues seem to play a minor part
in vivo.
Consequently, the absence of bone formation is not due
to inappropriate functionalisation of the PLLA-collagen
scaffolds, but more likely a result of unbalanced
colonization of the scaffolds with cells due to insufficient
pore size.
If it is possible to overcome limitations of pore sizes,
either by sacrificial fibers, [37, 38], variations in fiber
diameter [39], incorporation of salt or ice crystals [36, 40]
or direct incorporation of cells [41] the scaffolds presented
here could serve as a suitable implant for bone repair.
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